Home The Word Brain My Amedeo FAQ Privacy About


Hanzi Hunter

Learning 500 Chinese characters in 30 days is possible.

Abstract • About

  Gastric Cancer

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 21 articles:
HTML format



Single Articles


    March 2026
  1. PARK JY, Lee YC, Moayyedi P, Lansdorp-Vogelaar I, et al
    Helicobacter pylori Screen-and-Treat Programs for Gastric Cancer Prevention - IARC Working Group Report.
    N Engl J Med. 2026;394:1131-1137.
    PubMed    


    October 2025
  2. JANJIGIAN YY, Heilbron E, Tabernero J
    Perioperative Durvalumab in Gastric Cancer. Reply.
    N Engl J Med. 2025;393:1653-1654.
    PubMed    


  3. HOEPPNER J
    Perioperative Durvalumab in Gastric Cancer.
    N Engl J Med. 2025;393:1653.
    PubMed    


  4. LI S
    Perioperative Durvalumab in Gastric Cancer.
    N Engl J Med. 2025;393:1652-1653.
    PubMed    


  5. SHITARA K
    Trastuzumab Deruxtecan in Gastric Cancer. Reply.
    N Engl J Med. 2025;393:1347-1348.
    PubMed    


  6. SUTO H
    Trastuzumab Deruxtecan in Gastric Cancer.
    N Engl J Med. 2025;393:1347.
    PubMed    


    July 2025
  7. SHITARA K
    New Perioperative Strategy in Gastric Cancer.
    N Engl J Med. 2025;393:302-303.
    PubMed    


  8. JANJIGIAN YY, Al-Batran SE, Wainberg ZA, Muro K, et al
    Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer.
    N Engl J Med. 2025;393:217-230.
    PubMed     Abstract available


    May 2025
  9. SHITARA K, Van Cutsem E, Gumus M, Lonardi S, et al
    Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric Cancer.
    N Engl J Med. 2025 May 31. doi: 10.1056/NEJMoa2503119.
    PubMed     Abstract available


    September 2024
  10. RUBIN EJ, Yeku OO, Morrissey S
    NEJM at ESMO - Zolbetuximab in Gastric or Gastroesophageal Junction Adenocarcinoma.
    N Engl J Med. 2024;391:e26.
    PubMed    


  11. SHITARA K, Shah MA, Lordick F, Van Cutsem E, et al
    Zolbetuximab in Gastric or Gastroesophageal Junction Adenocarcinoma.
    N Engl J Med. 2024;391:1159-1162.
    PubMed    


  12. RUBIN EJ, Yeku OO, Morrissey S
    NEJM at ESMO - Pembrolizumab in HER2+ Gastric Cancer.
    N Engl J Med. 2024 Sep 14. doi: 10.1056/NEJMe2411493.
    PubMed    


  13. RUBIN EJ, Yeku OO, Morrissey S
    NEJM at ESMO - Preoperative Chemoradiotherapy for Resectable Gastric Cancer.
    N Engl J Med. 2024 Sep 14. doi: 10.1056/NEJMe2411487.
    PubMed    


  14. JANJIGIAN YY, Kawazoe A, Bai Y, Xu J, et al
    Pembrolizumab in HER2-Positive Gastric Cancer.
    N Engl J Med. 2024 Sep 14. doi: 10.1056/NEJMc2408121.
    PubMed    


  15. LEONG T, Smithers BM, Michael M, Haustermans K, et al
    Preoperative Chemoradiotherapy for Resectable Gastric Cancer.
    N Engl J Med. 2024 Sep 14. doi: 10.1056/NEJMoa2405195.
    PubMed     Abstract available


    July 2023
  16. USUI Y, Matsuo K, Momozawa Y
    Helicobacter pylori, Homologous-Recombination Genes, and Gastric Cancer. Reply.
    N Engl J Med. 2023;389:379-381.
    PubMed    


  17. SORSCHER S
    Helicobacter pylori, Homologous-Recombination Genes, and Gastric Cancer.
    N Engl J Med. 2023;389:380.
    PubMed    


  18. FOULKES WD, Polak P, Karlic R
    Helicobacter pylori, Homologous-Recombination Genes, and Gastric Cancer.
    N Engl J Med. 2023;389:379-380.
    PubMed    


  19. ISHII N, Shiratori Y, Omata F
    Helicobacter pylori, Homologous-Recombination Genes, and Gastric Cancer.
    N Engl J Med. 2023;389:379.
    PubMed    


    March 2023
  20. MULLER A, He J
    A Double Whammy on Gastric Cancer Risk.
    N Engl J Med. 2023;388:1225-1229.
    PubMed    


  21. USUI Y, Taniyama Y, Endo M, Koyanagi YN, et al
    Helicobacter pylori, Homologous-Recombination Genes, and Gastric Cancer.
    N Engl J Med. 2023;388:1181-1190.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum